General Western Blot Reagents
Abcam Ingenol-3-angelate, PKC activator, 5MG
MW 430.5 Da, Purity >98%. Selective activator of PKC isoforms, like PKCθ in T cells. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Methyl 3-hydro x yhe x anoate, 3-Hydro x y fatty acid methyl ester, 25MG
MW 146.18 Da, Purity >98%. 3-Hydroxy fatty acid methyl ester. For use as standard in methanolysis assay and in biological systems. See similar products
The product is subject to the following: Abcam Restricted Use Statement
Abcam Asta x anthin, Antio x idant agent, 5MG
MW 596.8 Da, Purity >97%. Potent antioxidant agent. PPARα agonist and PPARγ antagonist. Free radical scavenger. Reduces oxidative stress. Induces apoptosis. Inhibits NF-κB. Shows anti-inflammatory, antihypertensive, cardioprotective, neuroprotective and antitumor effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ACTH (1-24) (human), ACTH/MC2 receptor agonist, 1MG
MW 2933.4 Da. ACTH (1-24) (human), ACTH/MC2 receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam C6 Ceramide, biologically active ceramide analog, 5MG
MW 397.6 Da, Purity >98%. Non-physiological and biologically active ceramide analog. Various pharmacological activities including activation of protein phosphatase 2A and MAPK, suppression of insulin-induced tyrosine phosphorylation and induction of cell cycle arrest at the G0/G1 transition. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride, condensing reagent, 10G
MW 191.7 g/mol. Water-soluble condensing reagent. Generally utilized as a carboxyl activating agent for amide bonding with primary amines. Additionally, it reacts with phosphate groups. Utilized in peptide synthesis, crosslinking proteins to nucleic acids as well as preparation of immunoconjugates.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-1,2-Didecanoylglycerol (10:0), Protein kinase C activator, 50MG
MW 400.6 g/mol, Purity >98%. Non-physiologic diacylglycerol (DAG). Cell-permeable protein kinase C activator in platelets. Enhances anterior pituitary hormone secretion in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AS601245, JNK inhibitor, 25MG
MW 372.4 Da, Purity >95%. Potent, selective, ATP competitive JNK inhibitor (IC₅₀ values are 150, 220 and 70 nM for hJNK1,2 and 3 respectively). Reduces cell adhesion and migration in cancer cells. Shows neuroprotective, anti-ischemic effects in vivo. Blood-brain barrier and cell-permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AICAR (Acadesine/AICA riboside) (aqueous solution), protein kinase activator, 50MG-LQD
MW 258.23 Da, Purity >98%. Cell-permeable activator of AMP-activated protein kinase. Is taken up into cells by adenosine transporters and phosphorylated by adenosine kinase to the active nucleotide ZMP (5-aminoimidazole-4-carboxamide ribonucleoside), which mimics effects of AMP on the AMPK system. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam G 418 sulfate (Geneticin sulfate), Aminoglycoside antibiotic agent, 1G
MW 692.7 Da. Aminoglycoside antibiotic agent. Potent Delta7-SMN target sequence inducer. Inhibits amino acid incorporation into proteins. Shows cytotoxic effects. Inhibits the prokaryotic and eukaryotic elongation cycle. Shows antibacterial and antiprotozoal effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Rhod-2 AM, fluorescent Ca2+ indicator, 1MG
Rhod-2 AM, a fluorescent Ca2+ indicator is cell-permeable. Binds to Ca2+ (Kd = 570 nM) and fluoresces yellow/orange upon Ca2+ binding. - Cited in over 20 publications - Purity > 93% - Soluble in DMSO to 1 mg/ml - Excitation/Emission: Ex: 552nm, Em: 581nm
The product is subject to the following: Abcam Restricted Use Statement
Abcam Docosa-4Z,7Z,10Z,13Z,16Z,19Z-he x aenoic acid, Anti-inflammatory agent, 100MG
MW 328.5 g/mol, Purity >98%. Abundant essential n-3 polyunsaturated fatty acid in the CNS, shown to play a major anti-inflammatory role. Prevents LPS-induced dendritic cell maturation, characterized by a lack of proinflammatory cytokine production. Improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Inhibits Aβ1-42 fibrillation and toxicity in vitro. Retinoid X receptor (RXR) ligand.
The product is subject to the following: Abcam Restricted Use Statement
Abcam VAS 2870, NADPH o x idase inhibitor, 10MG
MW 360.4 g/mol, Purity >98%. NADPH oxidase inhibitor. Blocks PDGF-mediated NADPH activation and ROS production. Inhibits PMS-induced oxidative burst (IC₅₀ = 2 μM, HeLa cells). Shows anti-ischemic effects ex vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Quinol 1h, Antitumor agent, 25MG
MW 365.4 Da, Purity >99%. Potent, selective antitumor agent. Antitumor activity observed in HCT 116 (GI₅₀ = 40 nM) and HT 29 (GI₅₀ = 380 nM), and in breast cancer cell lines. Potent inhibitory effect in NCI 60 cells (GI₅₀ =16 nM and LC₅₀ = 2.24 μM). Active in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MDL 72222, 5-HT3 receptor antagonist, 50MG
MW 314.21 g/mol, Purity >99%. Selective 5-HT₃ receptor antagonist. Shows antiemetic effects in vivo. Suppresses voluntary ethanol consumption that is mediated by 5-HT₃ receptor in rats.
The product is subject to the following: Abcam Restricted Use Statement